Citations

Clear

3138 citation(s) found for "Smith, AM".

Incidence of Bleeding After 15,181 Percutaneous Biopsies and the Role of Aspirin
Atwell, Thomas D. , Smith, R. L., Hesley, Gina K. , Callstrom, Matthew R. , Schleck, Cathy D. , Harmsen, William S. , Charboneau, J. William, Welch, Timothy J.

Mayo Clinic

American Journal of Roentgenology | February 19, 2010 | Volume: 194 | Issue: 3 | Pages: 784-789

10.2214/ajr.08.2122 | PMID 20173160 Get It

Acylcarnitine Analysis by Tandem Mass Spectrometry
Smith, Emily H., Matern, Dietrich

Mayo Clinic

Current Protocols in Human Genetics | January 15, 2010 | Volume: 64 | Issue: 1 | Pages: No page available

10.1002/0471142905.hg1708s64 | PMID 20063265 Get It

AbstractCarnitine plays an essential role in fatty acid metabolism, as well as modulation of intracellular concentrations of free coenzyme A by esterification of acyl residues. Acylcarnitine analysis of various biological fluids is a sensitive method to detect >20 inborn errors of metabolism that result in abnormal accumulation of acylcarnitine species due to several organic acidemias and most fatty acid β‐oxidation disorders. In addition, acylcarnitine analysis may aid in monitoring treatment of known patients affected with these inborn errors of metabolism. This unit describes protocols that can be used to measure acylcarnitine species of various carbon chain lengths in several biological specimen types including plasma, dried blood and bile spots, and urine, by derivatization to butylesters and flow‐injection electrospray ionization tandem mass spectrometry (ESI‐MS/MS). Curr. Protoc. Hum. Genet. 64:17.8.1‐17.8.20. © 2010 by John Wiley & Sons, Inc.
Brain-Derived Neurotrophic Factor Stimulates Production of Prostacyclin in Cerebral Arteries
Santhanam, Anantha Vijay R., Katušić, Zvonimir S. , Smith, Leslie

Mayo Clinic

Stroke | December 18, 2009 | Volume: 41 | Issue: 2 | Pages: 350-356

10.1161/strokeaha.109.564492 | PMID 20019327 Get It

Background and Purpose— The role of brain-derived neurotrophic factor (BDNF) and its receptor, tropomyosin receptor kinase B, in control of cerebral circulation is poorly understood. The present study was designed to investigate the cerebral vascular effects of BDNF in vivo. Methods— Replication incompetent adenovirus encoding either rat BDNF (AdBDNF) or green fluorescent protein was injected intracisternally into rabbits. Forty-eight hours later, animals were euthanized. Plasma and cerebrospinal fluid levels of BDNF were measured by enzyme-linked immunosorbent assay, vasomotor function of isolated basilar arteries was studied in organ chambers, protein expression in the basilar arteries was studied by Western blotting, prostanoid levels were measured by enzyme-linked immunosorbent assay, and cyclic adenosine 3′,5′-monophosphate levels were measured by radioimmunoassay. Results— The levels of BDNF in the cerebrospinal fluid were significantly elevated in AdBDNF-treated rabbits as compared with adenovirus encoding green fluorescent protein-treated rabbits (37±5 ng/mL versus 0.006±0.003 ng/mL, respectively; P <0.05; n=14). Western blotting studies revealed that in basilar arteries, AdBDNF increased protein expression of prostacyclin synthase, whereas expression of endothelial nitric oxide synthase and phosphorylated (Ser 1177) endothelial nitric oxide synthase remained unchanged. During incubation with arachidonic acid (1 μmol/L), PGI 2 production and levels of cyclic adenosine 3′,5′-monophosphate were significantly elevated only in AdBDNF-treated rabbit basilar arteries ( P <0.05, n=6). Relaxations to acetylcholine (10 −9 to 10 −5 mol/L) and arachidonic acid (10 −9 to 10 −5 mol/L) were significantly potentiated in basilar arteries from rabbits injected with AdBDNF. Potentiation of relaxations to acetylcholine in AdBDNF-treated basilar arteries was inhibited by the nonselective cyclooxygenase inhibitor, indomethacin (10 −5 mol/L, P <0.05, n=6) and constitutive phospholipase A 2 inhibitor, AACOCF3 (2×10 −5 mol/L, P <0.05, n=5). Conclusion— Our results demonstrate that in cerebral arteries, BDNF-induced activation of tropomyosin receptor kinase B receptor signaling in vivo promotes prostacyclin biosynthesis. These findings provide novel mechanistic insight into the vascular protective effect of BDNF in cerebral circulation.
Mutability in the Matrix Gene of Novel Influenza A H1N1 Virus Detected Using a FRET Probe-Based Real-Time Reverse Transcriptase PCR Assay
Dhiman, Neelam , Espy, Mark J., Irish, Cole L., Wright, Patty , Smith, Thomas F., Pritt, Bobbi S. , Pritt, Bobbi S

Mayo Clinic

Journal of Clinical Microbiology | December 17, 2009 | Volume: 48 | Issue: 2 | Pages: 677-679

10.1128/jcm.02225-09 | PMID 20018814 Get It

Effects of Cigarette Smoking on Psychopathology Scores in Patients with Schizophrenia: An Experimental Study
Infante, Mauricio, Ali, Akeela, Kotsaftis, Antonis, Smith, Robert Craft , Nigám, Sanjay K.

Mayo Clinic

Substance Abuse | December 16, 2009 | Volume: 22 | Issue: 3 | Pages: 175-186

10.1080/08897070109511457 | PMID 12466677 Get It

Cigarette smoking and/or nicotine administration have been shown to transiently ameliorate several psychophysiological deficits in patients with schizophrenia such as indicators of deficient sensory gating and attention, but acute effects of smoking on positive and negative symptoms in schizophrenia have not been evaluated in experimental paradigms. The current study assessed whether smoking of cigarettes, after 6–12 h abstinence, transiently alters the expression of negative and/or positive symptoms in patients with schizophrenia who have a history of regular smoking. In a double–blind, placebo controlled study patients with schizophrenia participated in two sessions in which they smoked either cigarettes moderately high in nicotine content or denicotinized cigarettes. They were interviewed pre–and postsmoking to obtain ratings of PANSS and SANS scales, and had blood pressure and pulse serially recorded before and after smoking. Pulse rate and blood pressure were slightly higher after smoking in the high nicotine cigarette session. Negative symptom scores on both scales were significantly lower after cigarette smoking compared to same–day predrug baseline, but there were no differences in active versus denicotinized cigarette drug effects. These results suggest that acute smoking of cigarettes reduces negative symptoms in patients with schizophrenia in this experimental paradigm. Future work needs to identify the mechanism responsible for this behavioral effect.
Differential Responses to Smith D Autoantigen by Mice with HLA-DR and HLA-DQ Transgenes: Dominant Responses by HLA-DR3 Transgenic Mice with Diversification of Autoantibodies to Small Nuclear Ribonucleoprotein, Double-Stranded DNA, and
Jiang, Chao , Deshmukh, Umesh S. , Gaskin, Felicia, Bagavant, Harini , Hanson, Julie A., David, Chella S., Fu, Shu Man

Mayo Clinic

The Journal of Immunology | December 10, 2009 | Volume: 184 | Issue: 2 | Pages: 1085-1091

10.4049/jimmunol.0902670 | PMID 20007529 Get It

Abstract Anti-Smith (Sm) D autoantibodies are specific for systemic lupus erythematosus. In this investigation, the influence of HLA-D genes on immune responses to SmD was investigated. Mice with HLA-DR3, HLA-DR4, HLA-DQ0601, HLA-DQ0604, or HLA-DQ8 transgenes were immunized with recombinant SmD1, and their Ab responses were analyzed. Analysis by ELISA showed that all strains responded well to SmD. However, when synthetic SmD peptides were used as substrate, DR3 mice had the highest Ab response followed by DQ8, DQ0604, DQ0601, and DR4. A similar trend was observed in Western blot analysis using WEHI 7.1 cell lysate as the substrate, with the exception that DR4 mice did not generate detectable amounts of Abs. Only sera from DR3 and DQ0604 mice immunoprecipitated A-ribonucleoprotein (RNP), SmB, and SmD. Intermolecular epitope spreading to A-RNP and SmB was evident in DR3 and DQ0604 mice, as sera depleted of anti-SmD Abs were reactive with these proteins. DR3 mice also generated an immune response to C-RNP. Anti-nuclear Abs were detected in the majority of the DR3 mice, whereas moderate reactivities were seen in DQ0604 and DQ8 mice. Interestingly, only DR3 mice mounted an anti-dsDNA Ab response. Approximately half of the anti-dsDNA Abs were cross-reactive with SmD. Ab responses correlated with the strength of the T cell responses. Thus, HLA-DR3 appears to be the dominant HLA-D gene that determines the magnitude and quality of the anti-SmD immune response. In addition, our findings provide insights into the origin of the anti-dsDNA Abs often detected in patients with systemic lupus erythematosus.
Spine Care: Evaluation of the Efficacy and Cost of Emerging Technology
Smith, Harvey E. , Rihn, Jeffrey A. , Guyer, Richard D., Coric, Dom, Lonner, Baron S. , Shelokov, Alexis, Currier, Bradford L. , Riley, Lee H. , Phillips, Frank M. , Albert, Todd J. , Brodke, Darrel Scott

Mayo Clinic

American Journal of Medical Quality | November 4, 2009 | Volume: 24 | Issue: 6_suppl | Pages: 25S-31S

10.1177/1062860609349312 | PMID 19890182 Get It

Pearls & Oy-sters: The orbital bruit
Smith, Jonathan , Fugate, Jennifer E. , Claassen, Daniel O.

Mayo Clinic

Neurology | October 19, 2009 | Volume: 73 | Issue: 16 | Pages: No page available

10.1212/wnl.0b013e3181bd138d | PMID 19841375 Get It

Expression of Insulin Receptor Isoform A and Insulin-like Growth Factor-1 Receptor in Human Acute Myelogenous Leukemia: Effect of the Dual-Receptor Inhibitor BMS-536924 In vitro
Hendrickson, Andrea E. Wahner , Haluska, Paul , Schneider, Paula A., Loegering, David A., Peterson, Kevin L., Attar, Ricardo M. , Erlichman, Charles , Gottardis, Marco M. , Karp, Judith E. , Carboni, Joan M., Peterson, Kevin L., Smith, B. Douglas , Kaufmann, Scott H.

Mayo Clinic

Cancer Research | September 29, 2009 | Volume: 69 | Issue: 19 | Pages: 7635-7643

10.1158/0008-5472.can-09-0511 | PMID 19789352 Get It

Abstract The insulin receptor (IR) and insulin-like growth factor-1 receptor (IGF1R) are receptor tyrosine kinases that participate in mitogenic and antiapoptotic signaling in normal and neoplastic epithelia. In the present study, immunoblotting and reverse transcription-PCR demonstrated expression of IGF1R and IR isoform A in acute myelogenous leukemia (AML) cell lines as well as in &gt;80% of clinical AML isolates. Treatment with insulin enhanced signaling through the Akt and MEK1/2 pathways as well as survival of serum-starved AML cell lines. Conversely, treatment with BMS-536924, a dual IGF1R/IR kinase inhibitor that is undergoing preclinical testing, inhibited constitutive receptor phosphorylation as well as downstream signaling through MEK1/2 and Akt. These changes inhibited proliferation and, in some AML cell lines, induced apoptosis at submicromolar concentrations. Likewise, BMS-536924 inhibited leukemic colony formation in CD34+ clinical AML samples in vitro. Collectively, these results not only indicate that expression of IGF1R and IR isoform A is common in AML but also show that interruption of signaling from these receptors inhibits proliferation in clinical AML isolates. Accordingly, further investigation of IGF1R/IR axis as a potential therapeutic target in AML appears warranted. [Cancer Res 2009;69(19):7635–43]
Aspirin for the Primary Prevention of Cardiovascular Events
Calvin, Andrew D. , Aggarwal, Niti R., Murad, M. Hassan , Shi, Qian , Elamin, Mohamed B., Geske, Jeffrey B. , Fernández-Balsells, Mercè , Lampropulos, Julianna F., Erwin, Patricia J., Smith, Steven A., Montori, Víctor M. , Albuquerque, Felipe N. , Murad, M Hassan , Montori, Victor M , Shi, Qian , Geske, Jeffrey B , Calvin, Andrew D

Mayo Clinic

Diabetes Care | September 9, 2009 | Volume: 32 | Issue: 12 | Pages: 2300-2306

10.2337/dc09-1297 | PMID 19741185 Get It

OBJECTIVE The negative results of two randomized controlled trials (RCTs) have challenged current guideline recommendations for using aspirin for primary prevention of cardiovascular events among patients with diabetes. We therefore sought to determine if the effect of aspirin for primary prevention of cardiovascular events and mortality differs between patients with and without diabetes. RESEARCH DESIGN AND METHODS We conducted a systematic search of MEDLINE, EMBASE, Cochrane Library, Web of Science, and Scopus since their inceptions until November 2008 for RCTs of aspirin for primary prevention of cardiovascular events. Blinded pairs of reviewers evaluated studies and extracted data. Random-effects meta-analysis and Bayesian logistic regression were used to estimate the ratios of relative risks (RRs) of outcomes of interest among patients with and without diabetes. A 95% CI that crosses 1.00 indicates that the effect of aspirin does not differ between patients with and without diabetes. RESULTS Nine RCTs with moderate to high methodological quality contributed data to the analyses. The ratios of RRs comparing the benefit of aspirin among patients with diabetes compared with patients without diabetes for mortality, myocardial infarction, and ischemic stroke were 1.12 (95% CI 0.92–1.35), 1.19 (0.82–1.17), and 0.70 (0.25–1.97), respectively. CONCLUSIONS Whereas estimates of benefit among patients with diabetes remain imprecise, our analysis suggests that the relative benefit of aspirin is similar in patients with and without diabetes.